SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021125
Filing Date
2020-11-12
Accepted
2020-11-12 16:50:49
Documents
86
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 695801
2 ex31.htm EX-31 34455
3 ex32.htm EX-32 8777
  Complete submission text file 0001493152-20-021125.txt   5511450

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ocx-20200930.xml EX-101.INS 1016392
5 XBRL SCHEMA FILE ocx-20200930.xsd EX-101.SCH 82993
6 XBRL CALCULATION FILE ocx-20200930_cal.xml EX-101.CAL 95132
7 XBRL DEFINITION FILE ocx-20200930_def.xml EX-101.DEF 246984
8 XBRL LABEL FILE ocx-20200930_lab.xml EX-101.LAB 497953
9 XBRL PRESENTATION FILE ocx-20200930_pre.xml EX-101.PRE 375977
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 201307611
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences